ascopubs.org

Propensity score (PS) comparison between lisocabtagene maraleucel (liso-cel) plus ibrutinib ...

Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. Preliminary safety and efficacy data of ...